RhumbLine Advisers
GEVA

RhumbLine Advisers’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

RhumbLine Advisers’s Portfolio GEVA Stock Details GEVA Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
2015
Q1 		$2.36M Buy
2014
Q4 		$1.79M Buy
2014
Q3 		$1.26M Sell
2014
Q2 		$2.06M Buy
2014
Q1 		$1.42M Buy
2013
Q4 		$1.1M Buy
2013
Q3 		$978K Sell
2013
Q2 		$651K Buy